Orders for the company’s AQS3pro™ platform grew over 500% in the second full year since product launch, and the company closed a $6.4 million Series D Preferred Stock extension to support continued aggressive growth in 2021. Burlington, MA – February 18th, 2021 RedShift BioAnalytics, Inc. (www.redshiftbio.com), a provider of innovative analytical solutions for protein characterization used […]
Illumina, Inc. (Nasdaq: ILMN) today announced an agreement with the Institute of Medical Genetics and Applied Genomics at the University Hospital of Tübingen to assess the value of whole-genome sequencing (WGS) as a first-line diagnostic test for patients with genetic diseases and familial cancer syndromes. Illumina will support the new investigator-initiated study, called the Ge-Med […]
HighCape Capital Acquisition Corporation The transaction will merge Quantum-Si’s revolutionary, end-to-end proteomics solution, and HighCape Capital Acquisition Corp., a healthcare-focused SPAC sponsored by leading healthcare growth equity investment firm HighCape Capital LP. The transaction is further supported by an oversubscribed $425 million PIPE with participation from leading institutional investors, including Foresite Capital Management, LLC, Eldridge, […]
Partner program designed to advance Sample to Insight solutions from research to patients leveraging QIAGEN’s unique Knowledge Base Five initial partners sign with QIAGEN Digital Insights (QDI) to grow QIAGENs unique genomic Knowledge Base and accelerate access New partnerships to deliver improved AI services and databases in oncology, secondary analysis and combined NGS panels and […]
Parse Biosciences (https://www.parsebiosciences.com/), a company providing researchers with scalable and flexible single-cell sequencing solutions, announced the launch of its Single Cell Whole Transcriptome Kit. The kit, which was previously available only through Parse’s early-access program, is now generally available to all researchers in North America. The Whole Transcriptome Kit from Parse Biosciences contains everything needed […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Labcorp (NYSE: LH), a leading global life sciences company, has increased its commitment to highly accurate HiFi sequencing with the addition of new PacBio® Sequel® II Systems. The new systems will expand Labcorp’s capacity to […]
– Focus on Rare Disease Prenatal and Pediatric Genetic Screening Services – SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Victorian Clinical Genetic Services (VCGS), an Australian-based specialist provider of prenatal, childhood and adult genetics […]
AMSBIO has introduced a collection of mutated SARS-CoV-2 spike proteins and recombinant antigens for the new virus variants – B.1.1.7 and B.1.351. These reagents can be used by researchers to evaluate the efficacy of the antibodies and identify targets for development of improved therapeutic drugs and vaccines. Emerging in the latter part of 2020, multiple new […]
Technology Visionary will Offer Strategic Insight to Guide Ongoing Research & Development of Market Leading Organ-on-a-Chip Technology BOSTON, Mass. – Emulate, Inc., a leading provider of organ-on-a-chip technology today announced the appointment of Donald Ingber, M.D., Ph.D., to its Board of Directors. Ingber, the scientific founder of Emulate and Chairman of its Scientific Advisory Board […]
Enhanced data quality, easier workflow, and more versatile analytics using fewer cell numbers SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today introduced the Agilent Seahorse XF HS Miniplate designed specifically for the Agilent Seahorse XF HS Mini Analyzer for improved immune cell metabolic analysis. Immunology and disease researchers are increasingly using rare, ex vivo, and genetically engineered cells to build […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
